Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Transfection Technologies Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size of transfection technologies has seen substantial growth. The market is expected to rise from $1.21 billion in 2024 to $1.32 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth in the historical period include the rising prevalence of chronic illnesses, wider usage of transfection technologies, an increase in demand for cell and gene therapy, boosts in R&D investment, and a surge in cancer cases.

What Is the Forecast for the Transfection Technologies Market Size Through 2029?

The market size of transfection technologies is predicted to experience significant expansion in the coming years, reaching $1.85 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%. This growth during the forecast period could be due to the increased prevalence of chronic and immunological diseases, a heightened need for therapy based on cells, a surge in protein production demands, growing investments and funding directed towards developing drug delivery systems, and an increased demand for monoclonal antibodies. During the forecast period, major trends include increased research and development activity in the domain of cell-based therapies, the adoption of cutting-edge transfection methods, an escalated demand for advanced therapeutic delivery systems, greater use of dual-reporter assays and co-transfection research, along with a growing emphasis on personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What are the Key Market Players in Transfection Technologies Market and How They’re Evolving?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

What Are the Primary Growth Drivers in the Transfection Technologies Market?

The advancement of gene therapy is predicted to accelerate the expansion of the transfection technologies market. Gene therapy, a method designed to treat or prevent diseases by altering genes, incorporates the processes of fixing, inserting, or substituting genes with errors. The escalation in gene therapy is propelled by advancements in genetic research, improved delivery mechanisms, and its potential to cure previously untreatable genetic disorders. Transfection technologies, integral to gene therapy, enable accurate, secure, and competent conveyance of genetic material into cells. These technologies assist both temporary and everlasting amendments in genome, critical for managing genetic illnesses and cancers. For example, the American Society of Gene & Cell Therapy (ASGCT) and Citeline, both US-based entities, stated in a report published in July 2023 that there were 247 Phase II gene therapies as of the first quarter (Q1) of 2023. This figure rose by 5% to 260 by the end of the second quarter (Q2). Therefore, the ascendancy of gene therapy is fuelling the expansion of the transfection technologies market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

What Are the Leading Segments in the Global Transfection Technologies Industry?

The transfection technologiesmarket covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Are the Key Market Trends in the Transfection Technologies Industry?

Key players in the transfection technologies market are investing in the creation of enhanced technology, such as mechanoporation transfection systems. These systems are aimed to support advanced and personalized applications in both research and therapy work. The mechanoporation transfection system, which hinges on the use of mechanical forces to produce temporary holes in cell membranes, allows genes to penetrate cells. This process is not only efficient but also minimally intrusive, ensuring high cell survivability. For example, in July 2024, a groundbreaking transfection system, CellPore, was unveiled by STEMCELL Technologies, a biotech firm based in Canada. This system comprises a benchtop unit and the CellPore Transfection Kit 300, furnished with a specialized reagent set and single-use dispensing cartridges. Through regulated, swift deformation within microfluidic channels, CellPore effectively permeates cells with small molecules, nucleic acids, proteins, and gene editing arrangements, maintaining minimal cell disruption and elevated viability. These attributes are pivotal in propelling research forward and developing innovative cell and gene treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Is the Regional Outlook for the Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228

This Report Delivers Insight On:

1. How big is the transfection technologies market, and how is it changing globally?

2. Who are the major companies in the transfection technologies market, and how are they performing?

3. What are the key opportunities and risks in the transfection technologies market right now?

4. Which products or customer segments are growing the most in the transfection technologies market?

5. What factors are helping or slowing down the growth of the transfection technologies market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model